ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
Nuclear Energy Conference & Expo (NECX)
September 8–11, 2025
Atlanta, GA|Atlanta Marriott Marquis
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Aug 2025
Jan 2025
Latest Journal Issues
Nuclear Science and Engineering
September 2025
Nuclear Technology
August 2025
Fusion Science and Technology
Latest News
Chris Wagner: The role of Eden Radioisotopes in the future of nuclear medicine
Chris Wagner has more than 40 years of experience in nuclear medicine, beginning as a clinical practitioner before moving into leadership roles at companies like Mallinckrodt (now Curium) and Nordion. His knowledge of both the clinical and the manufacturing sides of nuclear medicine laid the groundwork for helping to found Eden Radioisotopes, a start-up venture that intends to make diagnostic and therapeutic raw material medical isotopes like molybdenum-99 and lutetium-177.
Thomas H. Newton, Jr., Kent J. Riley, Peter J. Binns, Gordon E. Kohse, Lin-Wen Hu, Otto K. Harling
Nuclear Technology | Volume 139 | Number 2 | August 2002 | Pages 175-183
Technical Paper | Radiation Biology and Medicine | doi.org/10.13182/NT02-A3312
Articles are hosted by Taylor and Francis Online.
A new epithermal neutron irradiation facility, based on a fission converter assembly placed in the thermal column outside the reactor core, has been put into operation at the Massachusetts Institute of Technology Research Reactor (MITR). This facility was constructed to provide a high-intensity, forward-directed beam for use in neutron capture therapy with an epithermal flux of [approximately equal to]1010 n/cm2s at the medical room entrance with negligible fast neutron and gamma-ray contamination. The fission converter assembly consists of 10 or 11 MITR fuel elements placed in an aluminum tank and cooled with D2O. Thermal-hydraulic criteria were established based on heat deposition calculations. Various startup tests were performed to verify expected neutronic and thermal-hydraulic behavior. Flow testing showed an almost flat flow distribution across the fuel elements with <5% bypass flow. The total reactivity change caused by operation of the facility was measured at 0.014 ± 0.002% K/K. Thermal power produced by the facility was measured to be 83.1 ± 4.2 kW. All of these test results satisfied the thermal-hydraulic safety criteria. In addition, radiation shielding design measurements were made that verified design calculations for the neutronic performance.